Giuseppe Curigliano: 6/16 trained in the Oncology Specialization School of the University of Milan
Giuseppe Curigliano, Member of the Editorial Board for OncoDaily and President Elect of ESMO, shared a post by Paolo Tarantino, Research Fellow at Dana-Farber Cancer Institute, adding:
“The numbers: 6/16 trained in the Oncology Specialization School of the University of Milan! Large international training school.”
Quoting Paolo Tarantino‘s post:
“Proud to be part of the Italian winners of the ASCO Conquer Merit Award 2025!
The papers I will present at this year’s congress exemplify my scientific mission:
Develop new conjugated antibodies to improve the prognosis of breast cancer patients validate biomarkers that allow personalization of antibody conjugate therapies identify subgroups of patients for whom ‘less is more’ — i.e. chemotherapy can be omitted without risk
A long and tortuous path, made possible by multiple mentors, the funds donated for research and the courageous patients who participate in our research.
Thank you Conquer Cancer, the ASCO Foundation for the award and thank you Irma D’Aria and La Repubblica for the mention.
Link.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023